Metabolites (Jan 2023)

Mucopolysaccharidosis Type 1 among Children—Neuroradiological Perspective Based on Single Centre Experience and Literature Review

  • Magdalena Machnikowska-Sokołowska,
  • Aleksandra Myszczuk,
  • Emilia Wieszała,
  • Dominika Wieja-Błach,
  • Ewa Jamroz,
  • Justyna Paprocka

DOI
https://doi.org/10.3390/metabo13020209
Journal volume & issue
Vol. 13, no. 2
p. 209

Abstract

Read online

Mucopolysaccharidosis 1 (MPS 1) is a group of rare lysosomal genetic disorders resulting from the accumulation of undegraded glycosaminoglycans (GAGs) leading to multiorgan damage. Neurological symptoms vary from mild to severe. Neuroimaging—mainly magnetic resonance (MRI)—plays a crucial role in disease diagnosis and monitoring. Early diagnosis is of the utmost importance due to the necessity of an early therapy implementation. New imaging tools like MR spectroscopy (MRS), semiquantitative MRI analysis and applying scoring systems help substantially in MPS 1 surveillance. The presented analysis of neuroimaging manifestations is based on 5 children with MPS 1 and a literature review. The vigilance of the radiologist based on knowledge of neuroradiological patterns is highlighted.

Keywords